Catheter ablation of atrial fibrillation in patients with heart failure with reduced ejection fraction: Real world experience from six European centers.


Journal

Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756

Informations de publication

Date de publication:
08 2019
Historique:
received: 29 01 2019
revised: 16 05 2019
accepted: 04 06 2019
pubmed: 14 6 2019
medline: 29 9 2020
entrez: 14 6 2019
Statut: ppublish

Résumé

Catheter ablation of atrial fibrillation (AF) has been recently shown to have an impact on the outcome of patients with heart failure and reduced LV ejection fraction (LVEF). We aimed to assess patients with reduced LVEF referred to catheter ablation of AF, and the efficacy and safety of this procedure compared with healthier patients. 2083 consecutive procedures of catheter ablation of AF in six centers were divided into two groups on the basis of LVEF (≤ vs >35%) and comparisons were performed regarding procedural safety and efficacy. Only 51 (2.4%) of patients had low LVEF. Complication rate was comparable: 8.0% vs 6.9% (P = .760). Low LVEF patients are more frequently in persistent AF at the time of the procedure, have a higher degree of left atrial dilation, and higher CHA Patients with reduced LVEF account for only a minority of patients undergoing catheter ablation of AF. However, ablation appears to be as safe as for the general population, and albeit the efficacy seems lower, this appears to be driven by other comorbidities or features, which are more frequent in this population.

Identifiants

pubmed: 31190350
doi: 10.1111/jce.14027
doi:

Types de publication

Comparative Study Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1270-1277

Subventions

Organisme : UCLH Biomedicine NIHR funding
Pays : International

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Rui Providência (R)

Arrhythmia Department, Clinic Pasteur of Toulouse, Toulouse, France.
Arrhythmia Department, St. Bartholomew's Hospital, Barts Health NHS Trust, London, UK.
Institute of Health Informatics Research, University College of London, London, UK.

Carlo de Asmundis (C)

Heart Rhythm Management Centre, Universiteit Ziekenhuis Brussel, Postgraduate Program in Cardiac Electrophysiology and Pacing, Vrije Universiteit Brussel, Brussels, Belgium.

Julian Chun (J)

Cardioangiologisches Centrum Bethanien, Medizinische Klinik III, Markus Krankenhaus, Frankfurt am Main, Germany.

Gianbattista Chierchia (G)

Heart Rhythm Management Centre, Universiteit Ziekenhuis Brussel, Postgraduate Program in Cardiac Electrophysiology and Pacing, Vrije Universiteit Brussel, Brussels, Belgium.

Pascal Defaye (P)

Unité de rythmologie et stimulation cardiaque, CHU Michallon, Grenoble, France.

Frédéric Anselme (F)

Cardiology Department, University Hospital, Rouen, France.

Antonio Creta (A)

Arrhythmia Department, St. Bartholomew's Hospital, Barts Health NHS Trust, London, UK.

Pier D Lambiase (PD)

Arrhythmia Department, St. Bartholomew's Hospital, Barts Health NHS Trust, London, UK.

Boris Schmidt (B)

Cardioangiologisches Centrum Bethanien, Medizinische Klinik III, Markus Krankenhaus, Frankfurt am Main, Germany.

Shaojie Chen (S)

Cardioangiologisches Centrum Bethanien, Medizinische Klinik III, Markus Krankenhaus, Frankfurt am Main, Germany.

Ross J Hunter (RJ)

Arrhythmia Department, St. Bartholomew's Hospital, Barts Health NHS Trust, London, UK.

Stephane Combes (S)

Arrhythmia Department, Clinic Pasteur of Toulouse, Toulouse, France.

Shohreh Honarbakhsh (S)

Arrhythmia Department, St. Bartholomew's Hospital, Barts Health NHS Trust, London, UK.

Nicolas Combes (N)

Arrhythmia Department, Clinic Pasteur of Toulouse, Toulouse, France.

Maria Joao Sousa (MJ)

Arrhythmia Department, Clinic Pasteur of Toulouse, Toulouse, France.

Zeynab Jebberi (Z)

Arrhythmia Department, Clinic Pasteur of Toulouse, Toulouse, France.

Jean-Paul Albenque (JP)

Arrhythmia Department, Clinic Pasteur of Toulouse, Toulouse, France.

Serge Boveda (S)

Arrhythmia Department, Clinic Pasteur of Toulouse, Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH